Inogen, Inc. appointed Andrew (Andy) Reding to serve as Executive Vice President and Chief Operating Officer, effective July 6, 2026. Mr. Reding's compensation package includes a $500,000 annual base salary, a 70% target annual performance bonus, a $100,000 sign-on bonus, and an award of 130,000 time-based restricted stock units. Inogen, Inc. is a medical device company that provides oxygen concentrator technology for home use.
